XBIOTECH INC. — Operating Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8d99506e-d0d3-446e-9480-4562f83dfb3b/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-55.7M | 2025-01-01 – 2025-12-31 | evidence 0001171843-26-001561 |
| FY 2024 | $-42.5M | 2024-01-01 – 2024-12-31 | evidence 0001171843-25-001527 |
| FY 2023 | $-37.5M | 2023-01-01 – 2023-12-31 | evidence 0001171843-24-001382 |
| FY 2022 | $-34.5M | 2022-01-01 – 2022-12-31 | evidence 0001171843-23-001705 |
| FY 2021 | $-25.1M | 2021-01-01 – 2021-12-31 | evidence 0001171843-22-001904 |
| FY 2020 | $-18.3M | 2020-01-01 – 2020-12-31 | evidence 0001171843-21-001828 |
| FY 2019 | $-31.2M | 2019-01-01 – 2019-12-31 | evidence 0001171843-20-001761 |
| FY 2018 | $-21.0M | 2018-01-01 – 2018-12-31 | evidence 0001171843-19-001708 |
| FY 2017 | $-34.1M | 2017-01-01 – 2017-12-31 | evidence 0001171843-18-002043 |
| FY 2016 | $-52.8M | 2016-01-01 – 2016-12-31 | evidence 0001171843-17-001571 |
| FY 2015 | $-37.5M | 2015-01-01 – 2015-12-31 | evidence 0001171843-16-008925 |
| FY 2014 | $-21.8M | 2014-01-01 – 2014-12-31 | evidence 0001171843-16-008925 |
| FY 2013 | $-9.9M | 2013-01-01 – 2013-12-31 | evidence 0001171843-16-008925 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).